1. Home
  2. OSIS vs ZLAB Comparison

OSIS vs ZLAB Comparison

Compare OSIS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • ZLAB
  • Stock Information
  • Founded
  • OSIS 1987
  • ZLAB 2013
  • Country
  • OSIS United States
  • ZLAB China
  • Employees
  • OSIS N/A
  • ZLAB N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • ZLAB Health Care
  • Exchange
  • OSIS Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • OSIS 2.8B
  • ZLAB 3.0B
  • IPO Year
  • OSIS 1997
  • ZLAB 2017
  • Fundamental
  • Price
  • OSIS $166.56
  • ZLAB $26.05
  • Analyst Decision
  • OSIS Strong Buy
  • ZLAB Strong Buy
  • Analyst Count
  • OSIS 5
  • ZLAB 3
  • Target Price
  • OSIS $179.00
  • ZLAB $55.00
  • AVG Volume (30 Days)
  • OSIS 180.7K
  • ZLAB 482.4K
  • Earning Date
  • OSIS 01-23-2025
  • ZLAB 02-25-2025
  • Dividend Yield
  • OSIS N/A
  • ZLAB N/A
  • EPS Growth
  • OSIS 41.23
  • ZLAB N/A
  • EPS
  • OSIS 7.68
  • ZLAB N/A
  • Revenue
  • OSIS $1,603,555,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • OSIS $11.52
  • ZLAB $49.04
  • Revenue Next Year
  • OSIS $5.19
  • ZLAB $46.70
  • P/E Ratio
  • OSIS $21.68
  • ZLAB N/A
  • Revenue Growth
  • OSIS 24.35
  • ZLAB 35.01
  • 52 Week Low
  • OSIS $126.25
  • ZLAB $13.48
  • 52 Week High
  • OSIS $189.13
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 49.99
  • ZLAB 50.14
  • Support Level
  • OSIS $150.84
  • ZLAB $23.82
  • Resistance Level
  • OSIS $168.20
  • ZLAB $25.64
  • Average True Range (ATR)
  • OSIS 4.88
  • ZLAB 1.24
  • MACD
  • OSIS -0.35
  • ZLAB 0.06
  • Stochastic Oscillator
  • OSIS 61.45
  • ZLAB 64.45

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: